Medical Devices Investors & VC Firms

1641 firms in this list, with a median first check of $500K. 343 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
19 1955 Capital ACAHETJZ6 people · Follows rounds	88🔒	San Francisco	US	Pre-Seed–Series A	$5M – $10M	+ Add to CRM
NU Nurse Capital BADWLRMW9 people	88🔒	Chicago	US	Pre-Seed–Series A	$2M – $5M	+ Add to CRM
TA Taiho Ventures, LLC SAHKSMTI6 people	88🔒	Menlo Park	US	Seed–Series A	—	+ Add to CRM
TR Tramway Venture Partners WTCJKRJJ9 people	88🔒	New Mexico	US	Seed–Series A	$30M	+ Add to CRM
VE Ventac Partners MØRLCADW12 people	88🔒	Gentofte	DK	—	—	+ Add to CRM
CC CCV Capital WZJLNNYL14 people · Follows rounds	88🔒	Beijing	CN	Seed–Series B	—	+ Add to CRM
NG NGT Healthcare 2 NMZGLBTK8 people	88🔒	Nazareth	IL	Seed–Series A	—	+ Add to CRM
PA Pave Health Ventures JRNGAHAW11 people	88🔒	Seattle	US	Pre-Seed–Seed	—	+ Add to CRM
LI Liebenthal Ventures RBSL2 people	88🔒	Old Westbury	US	Pre-Seed–Seed	$25K – $500K	+ Add to CRM
NE Netrix Ventures ŁGTR2 people	88🔒	—	PL	Pre-Seed–Series A	—	+ Add to CRM
CA Catalpa Ventures CGSRTGWE10 people · Leads rounds	88🔒	Grevenmacher	LU	Pre-Seed–Series A	$330K – $1.6M	+ Add to CRM
AL Almeda Ventures AGABIYTS12 people	88🔒	Tel Aviv	IL	Seed–Series A	—	+ Add to CRM
DI Diffusion Capital Partners AKFÖAKAK9 people · Follows rounds	88🔒	Istanbul	TR	Pre-Seed–Series A	$540K – $2.2M	+ Add to CRM
EC Ecliptic Capital ALMWWHJR9 people · Leads rounds	88🔒	Austin	US	Pre-Seed–Series A	$50K – $5M	+ Add to CRM
OC OCV Partners RRALCBHZ6 people · Leads rounds	88🔒	Los Angeles	US	Seed–Series C	—	+ Add to CRM
TH The Vertical Group JWRBE3 people	88🔒	Berkeley Heights	US	Seed–Series A	$250K – $5M	+ Add to CRM
BP BPEA EQT JETHHGJH8 people · Leads rounds	88🔒	—	SG	Growth–Late Stage	$50M – $3B	+ Add to CRM
VI Vital Venture Capital ACNCNLCA5 people · Leads rounds	88🔒	Washington	US	Series A–Growth	$1M – $3M	+ Add to CRM
RO Robo Global LCBCRSSM10 people · Leads rounds	88🔒	New York	US	Seed–Series B	$500K – $2M	+ Add to CRM
WE Welltech Ventures AASBAKEA10 people	88🔒	Tel Aviv	IL	Seed–Series A	—	+ Add to CRM
ZO Zoic Capital NNMABIE13 people	88🔒	Seattle	US	Seed–Series A	—	+ Add to CRM
AC Access Biotechnology DBLRCB3 people · Leads rounds	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
AU AUM Ventures CMNSACDS6 people · Follows rounds	88🔒	India	IN	Pre-Seed–Series A	$750K – $2M	+ Add to CRM
FI Fides Capital Follows rounds	88🔒	Madrid	ES	Series A–Growth	$55K – $550K	+ Add to CRM

1955 Capital

San FranciscoPre-Seed–Series A$5M – $10M

ACAHETJZ6 people

Nurse Capital

ChicagoPre-Seed–Series A$2M – $5M

BADWLRMW9 people

Taiho Ventures, LLC

Menlo ParkSeed–Series A

SAHKSMTI6 people

Tramway Venture Partners

New MexicoSeed–Series A$30M

WTCJKRJJ9 people

Ventac Partners

Gentofte

MØRLCADW12 people

CCV Capital

BeijingSeed–Series B

WZJLNNYL14 people

NGT Healthcare 2

NazarethSeed–Series A

NMZGLBTK8 people

Pave Health Ventures

SeattlePre-Seed–Seed

JRNGAHAW11 people

Liebenthal Ventures

Old WestburyPre-Seed–Seed$25K – $500K

RBSL2 people

Netrix Ventures

Pre-Seed–Series A

ŁGTR2 people

Catalpa Ventures

GrevenmacherPre-Seed–Series A$330K – $1.6M

CGSRTGWE10 people

Almeda Ventures

Tel AvivSeed–Series A

AGABIYTS12 people

Diffusion Capital Partners

IstanbulPre-Seed–Series A$540K – $2.2M

AKFÖAKAK9 people

Ecliptic Capital

AustinPre-Seed–Series A$50K – $5M

ALMWWHJR9 people

OCV Partners

Los AngelesSeed–Series C

RRALCBHZ6 people

The Vertical Group

Berkeley HeightsSeed–Series A$250K – $5M

JWRBE3 people

BPEA EQT

Growth–Late Stage$50M – $3B

JETHHGJH8 people

Vital Venture Capital

WashingtonSeries A–Growth$1M – $3M

ACNCNLCA5 people

Robo Global

New YorkSeed–Series B$500K – $2M

LCBCRSSM10 people

Welltech Ventures

Tel AvivSeed–Series A

AASBAKEA10 people

Zoic Capital

SeattleSeed–Series A

NNMABIE13 people

Access Biotechnology

New YorkSeed–Late Stage

DBLRCB3 people

AUM Ventures

IndiaPre-Seed–Series A$750K – $2M

CMNSACDS6 people

Fides Capital

MadridSeries A–Growth$55K – $550K

Data sourced from public filings and firms' own websites — see our methodology.